Leptin and adiponectin regulate compensatory beta cell growth in accordance to overweight.
Compensatory beta cell growth occurs in accordance to overweight and increasing insulin demands. The proliferative actions of insulin and insulin-like growth factors are mediated via the IRS-2-PI(3)K-Akt pathway of pleiotropic insulin signaling. However, sustained activation leads to negative feedback via the mTOR-induced proteasomal degradation of IRS-2. The proliferative actions of incretins and adipokines are mediated via other pathways that ultimately converge with the IRS-2-PI(3)K-Akt axis. The incretins GIP and GLP-1 increase IRS-2 levels in beta cells by acting via the cAMP-PKA pathway, whereas leptin inhibits PTEN activity via CK2-dependent pathways. By increasing PIP(3) availability the adipokine amplifies the magnitude as well as duration of factors acting via the IRS-2-PI(3)K-Akt pathway. Considering that AMPK prevents mTOR-induced degradation of IRS-2, we propose that adiponectin and leptin cooperatively achieve compensatory beta cell growth in accordance to adiposity. In conditions of overt obesity, when adiponectin levels are too low to provide sufficient IRS-2 levels, loss of compensatory beta cell growth may occur.
Huypens
Peter Raymond
PR
V.U.B., Biochemistry, Laarbeeklaan 103, B-1090 Brussels, Brabant, Belgium. Peter.Huypens@vub.ac.be
D052242:Adiponectin / Q000378:metabolism*; D000818:Animals; D006801:Humans; D050417:Insulin-Secreting Cells / Q000378:metabolism*; D020738:Leptin / Q000378:metabolism*; D008954:Models, Biological; D050177:Overweight
D052242:Adiponectin; D020738:Leptin